Navigation Links
Nebulizer in Medical Technology

PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies

... COPD studies sponsored by DEY LP, PARI's LC Plus nebulizer and PRONEB compressors (Ultra and Ultra II) were ... researchers chose PARI products as the exclusive nebulizer systems for recent studies comparing maintenance ... to placebo/tiotropium. The PARI LC Plus nebulizer and PARI PRONEB Ultra compressor were used ...

Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM)

... once daily for 28 days using an eFlow(R) nebulizer System (PARI Pharma GmbH), a novel, highly ... About PARI Pharma and the eFlow (R) nebulizer System ARIKACE is delivered by an eFlow nebulizer System developed by PARI Pharma GmbH. The ...

PARI Pharma Reports Successful Phase Ib Clinical Results for Inhaled Liposomal Cyclosporine A and Gains FDA Orphan Drug Designation for the Prevention and Treatment of Bronchiolitis Obliterans

... for L-CsA, delivered via an Investigational eFlow nebulizer System, for the prevention and treatment of ... for administration via an Investigational eFlow nebulizer System without destroying the liposome," stated ... dose of 10mg L-CsA with an Investigational eFlow nebulizer System would give approximately 14 mg L-CsA/week. ...

PARI Pharma's Nebulized DSCG Shows Results Similar to Inhaled Steroids in Asthma Studies Presented at ATS

... a customized small droplet Investigational eFlow nebulizer System designed to deliver drugs to the deep ... (MMAD ~ 3.3 microns) Investigational eFlow nebulizer System has similar effects on asthma control, ... when administered via the Investigational eFlow nebulizer System," said Prof. Johannes Wildhaber, principal ...

Inspire's Phase 3 CF Trial, Using PARI's Nebulizer & Compressor, Shows Positive Top-Line Results

... inhalation solution delivered via PARI's LC STAR nebulizer and PRONEB Ultra compressor for the treatment of ... The combination of PARI's LC STAR breath-enhanced nebulizer and PRONEB Ultra compressor provides for a quick ... the PARI LC PLUS, and the new PARI LC Sprint nebulizer line, PARI also manufactures the award-winning ...

PARI's eFlow Delivers Alnylam RNAi Therapeutic in Phase II Study

... /PRNewswire/ -- An optimized PARI eFlow platform nebulizer will be delivering Alnylam's ALN-RSV01 in a Phase ... . About eFlow eFlow, an electronic, portable nebulizer platform, enables extremely efficient ... vibrating, perforated membrane. Compared to other nebulizer systems, eFlow can produce aerosols with a very ...

PARI Nebulizer & Compressor Used Exclusively in Inspire's Phase 3 CF Trial

... Va., March 10 /PRNewswire/ -- PARI's LC STAR nebulizer and PRONEB Ultra II compressor are the exclusive ... Equipment. "Our LC STAR is a fine particle nebulizer that enables delivery of aerosols to the smaller ... . The combination of PARI's LC STAR nebulizer and PRONEB Ultra II compressor provides for a ...

PARI's eFlow Included in Gilead's NDA Submission for Aztreonam Lysine for Inhalation

... 26 /PRNewswire/ -- PARI Pharma's eFlow electronic nebulizer was included in Gilead's (Nasdaq: GILD ) recent ... that produce the aerosol mist. Compared to other nebulizer systems, eFlow can produce aerosols with a ... inhalation drug development, including nebulizer formulation development and optimization, ...

Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis

... of levofloxacin inhaled solution delivered by an Investigational eFlow nebulizer System for use in cystic fibrosis (CF) and chronic obstructive pulmonary ... of MP-376 when administered by inhalation using an Investigational eFlow nebulizer System. All patients were required to be culture positive for P. ...

Mpex Initiates a Phase 2 Clinical Trial of Aerosol MP-376 in the Treatment of Chronic Bacterial Infections in Cystic Fibrosis Patients

... Pseudomonas aeruginosa. Administration of MP-376 with a high efficiency nebulizer to the lungs allows for the delivery of high concentrations of active drug ... Nebulizer, developed by PARI Pharma GmbH. eFlow(R) is a quiet portable nebulizer that enables efficient aerosolization of liquid medications via a ...

Cystic Fibrosis - Orphan Drug Designation for Innovative Treatment Against Lung Infections by Axentis Pharma AG

... proprietary Fluidosomes technology with the well-established generic drug tobramycin. Utilising synthetic liposomes containing tobramycin, a standard nebulizer delivers the drug directly to the endobronchial sites of infection in cystic fibrosis patients. This may result in prolonged high local drug ...

Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections

... Arikace is delivered by a novel inhalation device, the eFlow(R) Electronic Nebulizer, developed by PARI Pharma GmbH. eFlow is a quiet, portable nebulizer that enables efficient aerosolization of liquid medications, including liposomal formulations such as Arikace, via a vibrating perforated membrane. ...

Nektar Threraputics Announces Phase 2a Clinical Results Regarding the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative Hospital-Acquired Pneumonia Presented at the Annual American Thoracic Society International Conference

... that provides key advantages over traditional pneumatic or ultra-sonic nebulizer delivery. Hospital-acquired, gram-negative bacterial pneumonia is ... which provides key advantages over traditional pneumatic or ultra-sonic nebulizer delivery. Sources: ...

PARI and Kamada Announce Positive Intermediate Phase I Results for Inhaled Alpha-1 Antitrypsin

... liquid medications via a vibrating, perforated membrane. Compared to other nebulizer systems, eFlow can produce aerosols with a very high density of active ... PARI Pharma provides comprehensive inhalation drug development, including nebulizer formulation development and optimization, CMC, analytics, aerosol ...

Gilead Announces Presentation of Positive Phase III Data on Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis

... in the United States and Europe. About PARI and the eFlow Electronic nebulizer Aztreonam lysine is delivered through a novel inhalation device, the ... developed by PARI Pharma GmbH. The eFlow is an electronic, portable nebulizer that enables efficient aerosolization of liquid medications via a ...

Gilead Announces Achievement of Primary Efficacy Endpoint in Second Phase III Study of Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis

... the United States and Europe. About PARI Pharma and the eFlow Electronic nebulizer Aztreonam lysine for inhalation is delivered by a novel inhalation ... Nebulizer, developed by PARI Pharma GmbH. eFlow is a quiet, portable nebulizer that enables efficient aerosolization of liquid medications via a ...

PARI Pharma Presents Study Results of Sinus Delivery and Inhaled Liposomal Ciclosporin A at European Cystic Fibrosis Conference

... optimized to advanced delivery platforms, such as eFlow. Focusing on comprehensive inhalation therapy development, including optimized nebulizer formulations, analytics, and aerosol characterization, PARI Pharma has several clinical development programs ongoing, either partnered or ....
Other Contents
(Date:8/21/2014)... An international team of scientists including researchers from the University ... commonly known as canolain the journal Science . Their ... which is used widely in farming and industry. , ... Europe, but the winter crop is increasingly cultivated in Georgia. ... low levels of saturated fat and rich supply of omega-3 ...
(Date:8/21/2014)... Conn. , Aug. 21, 2014 Nxt-ID, ... the growing mobile commerce market, announced today that its ... common stock to be issued in its proposed underwritten ... approved for listing on The Nasdaq Capital Market, subject ... the common stock and warrants, and will trade under ...
(Date:8/21/2014)... and other itchy, flaky maladies in humans has now ... reefs and the extreme environments of arctic soils and ... journal PLOS Pathogens considers the diversity, ecology, ... Malassezia in light of new insights gained from ... University of Hawai,i at Mānoa scientist Anthony Amend discovered ...
Breaking Biology News(10 mins):Canola genome sequence reveals evolutionary 'love triangle' 2Nxt-ID Approved for NASDAQ Capital Market Listing 2Nxt-ID Approved for NASDAQ Capital Market Listing 3From dandruff to deep sea vents, an ecologically hyper-diverse fungus 2
(Date:8/22/2014)... DENVER For the first time an oncogenic somatic ... during transfection) protein has been identified in small cell ... mutation within SCLC cell lines produced increased intracellular signaling ... form of lung cancer representing 15% of all lung ... representing 85% of lung cancer, has been extensively examined ...
(Date:8/22/2014)... autoimmune disease that affects 1 to 2 percent ... with pain, disability and joint disfigurements, but also ... and marital functioning. While many pharmacological advances help ... common. In addition, some patients avoid newer medications ... Because of this, there is interest in psychosocial ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Restore ... Sen and Dr. Samantha Pearson to help people discover ... avoid corrective vision surgery by instead improving their eyesight ... an investigative review. , “There’s a reason why ... in revenue each year—it’s because people just assume that ...
(Date:8/22/2014)... New York (PRWEB) August 22, 2014 ... to be filed in U.S. courts on behalf ... due to their use of prescription low testosterone ... documents, a new claim was filed against Pfizer ... who allegedly suffered life-threatening heart issues due to ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Mueller Sports ... Plantar Fasciitis, an exciting new product that provides non-drug ... to stay active while you heal. The package includes ... truly a new technology – it is not kinesiology ... FasciaDerm® PFTape™ System for Plantar Fasciitis is ...
Breaking Medicine News(10 mins):Health News:Novel oncogenic RET mutation found in small cell lung cancer 2Health News:Study shows cognitive-behavioral coping skills training has positive effects on rheumatoid arthritis 2Health News:Restore My Vision Today: Review Exposes Natural Eye Restoration Guide by Dr. Sen and Dr. Samantha Pearson 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 4Health News:Mueller Introduces FasciaDerm® PFTape™ System for Plantar Fasciitis 2
Other TagsOther Tags